Global Medical Tranexamic Acid Market Growth 2023-2029

January 2023 | 113 pages | ID: G8907E21A55BEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Tranexamic acid is a white crystalline powder, odorless, slightly bitter in taste, easily soluble in water, almost insoluble in ethanol, acetone, chloroform or ether. Tranexamic acid is a medicine used to treat or prevent excessive blood loss due to major trauma, postpartum hemorrhage, surgery, tooth extraction, nosebleeds, or menorrhagia. It is also used for hereditary angioedema. It can be taken orally or given intravenously.

LPI (LP Information)' newest research report, the “Medical Tranexamic Acid Industry Forecast” looks at past sales and reviews total world Medical Tranexamic Acid sales in 2022, providing a comprehensive analysis by region and market sector of projected Medical Tranexamic Acid sales for 2023 through 2029. With Medical Tranexamic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Tranexamic Acid industry.

This Insight Report provides a comprehensive analysis of the global Medical Tranexamic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Tranexamic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Medical Tranexamic Acid market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Tranexamic Acid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Tranexamic Acid.

The global Medical Tranexamic Acid market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Medical Tranexamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Medical Tranexamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Medical Tranexamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Medical Tranexamic Acid players cover Pfizer, Wockhardt Ltd., FDC Limited, Taicang Pharmaceutical Factory, Asahi Kasei Finechem, Cipla, Taj Pharmaceutical Ltd., Wuhan Xinzekang Chemical Co., Ltd. and Vega Pharma Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Tranexamic Acid market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Tablet
  • Injection
  • Oral Liquid
Segmentation by application
  • Menstrual and Postoperative Bleeding
  • Whitening Acne
  • Hereditary Angioedema
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer
  • Wockhardt Ltd.
  • FDC Limited
  • Taicang Pharmaceutical Factory
  • Asahi Kasei Finechem
  • Cipla
  • Taj Pharmaceutical Ltd.
  • Wuhan Xinzekang Chemical Co., Ltd.
  • Vega Pharma Limited
  • Dalian Richon Chem Co., Ltd.
  • Nanjing Gemsen International Co., Ltd.
  • Changzhou Hangyu Pharmaceutical Technology Co.,Ltd.
  • Hunan Dongting Pharmaceuticals
  • Yinsheng Pharmaceutical
  • Mascot Industries
  • Alembic Ltd.
  • Hangzhou Lianzheng Chemicals Co., Ltd.
Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Tranexamic Acid market?

What factors are driving Medical Tranexamic Acid market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Tranexamic Acid market opportunities vary by end market size?

How does Medical Tranexamic Acid break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Medical Tranexamic Acid Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Medical Tranexamic Acid by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Medical Tranexamic Acid by Country/Region, 2018, 2022 & 2029
2.2 Medical Tranexamic Acid Segment by Type
  2.2.1 Tablet
  2.2.2 Injection
  2.2.3 Oral Liquid
2.3 Medical Tranexamic Acid Sales by Type
  2.3.1 Global Medical Tranexamic Acid Sales Market Share by Type (2018-2023)
  2.3.2 Global Medical Tranexamic Acid Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Medical Tranexamic Acid Sale Price by Type (2018-2023)
2.4 Medical Tranexamic Acid Segment by Application
  2.4.1 Menstrual and Postoperative Bleeding
  2.4.2 Whitening Acne
  2.4.3 Hereditary Angioedema
  2.4.4 Others
2.5 Medical Tranexamic Acid Sales by Application
  2.5.1 Global Medical Tranexamic Acid Sale Market Share by Application (2018-2023)
  2.5.2 Global Medical Tranexamic Acid Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Medical Tranexamic Acid Sale Price by Application (2018-2023)

3 GLOBAL MEDICAL TRANEXAMIC ACID BY COMPANY

3.1 Global Medical Tranexamic Acid Breakdown Data by Company
  3.1.1 Global Medical Tranexamic Acid Annual Sales by Company (2018-2023)
  3.1.2 Global Medical Tranexamic Acid Sales Market Share by Company (2018-2023)
3.2 Global Medical Tranexamic Acid Annual Revenue by Company (2018-2023)
  3.2.1 Global Medical Tranexamic Acid Revenue by Company (2018-2023)
  3.2.2 Global Medical Tranexamic Acid Revenue Market Share by Company (2018-2023)
3.3 Global Medical Tranexamic Acid Sale Price by Company
3.4 Key Manufacturers Medical Tranexamic Acid Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Medical Tranexamic Acid Product Location Distribution
  3.4.2 Players Medical Tranexamic Acid Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MEDICAL TRANEXAMIC ACID BY GEOGRAPHIC REGION

4.1 World Historic Medical Tranexamic Acid Market Size by Geographic Region (2018-2023)
  4.1.1 Global Medical Tranexamic Acid Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Medical Tranexamic Acid Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Tranexamic Acid Market Size by Country/Region (2018-2023)
  4.2.1 Global Medical Tranexamic Acid Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Medical Tranexamic Acid Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Tranexamic Acid Sales Growth
4.4 APAC Medical Tranexamic Acid Sales Growth
4.5 Europe Medical Tranexamic Acid Sales Growth
4.6 Middle East & Africa Medical Tranexamic Acid Sales Growth

5 AMERICAS

5.1 Americas Medical Tranexamic Acid Sales by Country
  5.1.1 Americas Medical Tranexamic Acid Sales by Country (2018-2023)
  5.1.2 Americas Medical Tranexamic Acid Revenue by Country (2018-2023)
5.2 Americas Medical Tranexamic Acid Sales by Type
5.3 Americas Medical Tranexamic Acid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Medical Tranexamic Acid Sales by Region
  6.1.1 APAC Medical Tranexamic Acid Sales by Region (2018-2023)
  6.1.2 APAC Medical Tranexamic Acid Revenue by Region (2018-2023)
6.2 APAC Medical Tranexamic Acid Sales by Type
6.3 APAC Medical Tranexamic Acid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Medical Tranexamic Acid by Country
  7.1.1 Europe Medical Tranexamic Acid Sales by Country (2018-2023)
  7.1.2 Europe Medical Tranexamic Acid Revenue by Country (2018-2023)
7.2 Europe Medical Tranexamic Acid Sales by Type
7.3 Europe Medical Tranexamic Acid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Medical Tranexamic Acid by Country
  8.1.1 Middle East & Africa Medical Tranexamic Acid Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Medical Tranexamic Acid Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Tranexamic Acid Sales by Type
8.3 Middle East & Africa Medical Tranexamic Acid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Tranexamic Acid
10.3 Manufacturing Process Analysis of Medical Tranexamic Acid
10.4 Industry Chain Structure of Medical Tranexamic Acid

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Medical Tranexamic Acid Distributors
11.3 Medical Tranexamic Acid Customer

12 WORLD FORECAST REVIEW FOR MEDICAL TRANEXAMIC ACID BY GEOGRAPHIC REGION

12.1 Global Medical Tranexamic Acid Market Size Forecast by Region
  12.1.1 Global Medical Tranexamic Acid Forecast by Region (2024-2029)
  12.1.2 Global Medical Tranexamic Acid Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Tranexamic Acid Forecast by Type
12.7 Global Medical Tranexamic Acid Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Medical Tranexamic Acid Product Portfolios and Specifications
  13.1.3 Pfizer Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 Wockhardt Ltd.
  13.2.1 Wockhardt Ltd. Company Information
  13.2.2 Wockhardt Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
  13.2.3 Wockhardt Ltd. Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Wockhardt Ltd. Main Business Overview
  13.2.5 Wockhardt Ltd. Latest Developments
13.3 FDC Limited
  13.3.1 FDC Limited Company Information
  13.3.2 FDC Limited Medical Tranexamic Acid Product Portfolios and Specifications
  13.3.3 FDC Limited Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 FDC Limited Main Business Overview
  13.3.5 FDC Limited Latest Developments
13.4 Taicang Pharmaceutical Factory
  13.4.1 Taicang Pharmaceutical Factory Company Information
  13.4.2 Taicang Pharmaceutical Factory Medical Tranexamic Acid Product Portfolios and Specifications
  13.4.3 Taicang Pharmaceutical Factory Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Taicang Pharmaceutical Factory Main Business Overview
  13.4.5 Taicang Pharmaceutical Factory Latest Developments
13.5 Asahi Kasei Finechem
  13.5.1 Asahi Kasei Finechem Company Information
  13.5.2 Asahi Kasei Finechem Medical Tranexamic Acid Product Portfolios and Specifications
  13.5.3 Asahi Kasei Finechem Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Asahi Kasei Finechem Main Business Overview
  13.5.5 Asahi Kasei Finechem Latest Developments
13.6 Cipla
  13.6.1 Cipla Company Information
  13.6.2 Cipla Medical Tranexamic Acid Product Portfolios and Specifications
  13.6.3 Cipla Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Cipla Main Business Overview
  13.6.5 Cipla Latest Developments
13.7 Taj Pharmaceutical Ltd.
  13.7.1 Taj Pharmaceutical Ltd. Company Information
  13.7.2 Taj Pharmaceutical Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
  13.7.3 Taj Pharmaceutical Ltd. Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Taj Pharmaceutical Ltd. Main Business Overview
  13.7.5 Taj Pharmaceutical Ltd. Latest Developments
13.8 Wuhan Xinzekang Chemical Co., Ltd.
  13.8.1 Wuhan Xinzekang Chemical Co., Ltd. Company Information
  13.8.2 Wuhan Xinzekang Chemical Co., Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
  13.8.3 Wuhan Xinzekang Chemical Co., Ltd. Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Wuhan Xinzekang Chemical Co., Ltd. Main Business Overview
  13.8.5 Wuhan Xinzekang Chemical Co., Ltd. Latest Developments
13.9 Vega Pharma Limited
  13.9.1 Vega Pharma Limited Company Information
  13.9.2 Vega Pharma Limited Medical Tranexamic Acid Product Portfolios and Specifications
  13.9.3 Vega Pharma Limited Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Vega Pharma Limited Main Business Overview
  13.9.5 Vega Pharma Limited Latest Developments
13.10 Dalian Richon Chem Co., Ltd.
  13.10.1 Dalian Richon Chem Co., Ltd. Company Information
  13.10.2 Dalian Richon Chem Co., Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
  13.10.3 Dalian Richon Chem Co., Ltd. Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Dalian Richon Chem Co., Ltd. Main Business Overview
  13.10.5 Dalian Richon Chem Co., Ltd. Latest Developments
13.11 Nanjing Gemsen International Co., Ltd.
  13.11.1 Nanjing Gemsen International Co., Ltd. Company Information
  13.11.2 Nanjing Gemsen International Co., Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
  13.11.3 Nanjing Gemsen International Co., Ltd. Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Nanjing Gemsen International Co., Ltd. Main Business Overview
  13.11.5 Nanjing Gemsen International Co., Ltd. Latest Developments
13.12 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd.
  13.12.1 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Company Information
  13.12.2 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
  13.12.3 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Main Business Overview
  13.12.5 Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Latest Developments
13.13 Hunan Dongting Pharmaceuticals
  13.13.1 Hunan Dongting Pharmaceuticals Company Information
  13.13.2 Hunan Dongting Pharmaceuticals Medical Tranexamic Acid Product Portfolios and Specifications
  13.13.3 Hunan Dongting Pharmaceuticals Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Hunan Dongting Pharmaceuticals Main Business Overview
  13.13.5 Hunan Dongting Pharmaceuticals Latest Developments
13.14 Yinsheng Pharmaceutical
  13.14.1 Yinsheng Pharmaceutical Company Information
  13.14.2 Yinsheng Pharmaceutical Medical Tranexamic Acid Product Portfolios and Specifications
  13.14.3 Yinsheng Pharmaceutical Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Yinsheng Pharmaceutical Main Business Overview
  13.14.5 Yinsheng Pharmaceutical Latest Developments
13.15 Mascot Industries
  13.15.1 Mascot Industries Company Information
  13.15.2 Mascot Industries Medical Tranexamic Acid Product Portfolios and Specifications
  13.15.3 Mascot Industries Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Mascot Industries Main Business Overview
  13.15.5 Mascot Industries Latest Developments
13.16 Alembic Ltd.
  13.16.1 Alembic Ltd. Company Information
  13.16.2 Alembic Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
  13.16.3 Alembic Ltd. Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Alembic Ltd. Main Business Overview
  13.16.5 Alembic Ltd. Latest Developments
13.17 Hangzhou Lianzheng Chemicals Co., Ltd.
  13.17.1 Hangzhou Lianzheng Chemicals Co., Ltd. Company Information
  13.17.2 Hangzhou Lianzheng Chemicals Co., Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
  13.17.3 Hangzhou Lianzheng Chemicals Co., Ltd. Medical Tranexamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 Hangzhou Lianzheng Chemicals Co., Ltd. Main Business Overview
  13.17.5 Hangzhou Lianzheng Chemicals Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Medical Tranexamic Acid Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Medical Tranexamic Acid Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Injection
Table 5. Major Players of Oral Liquid
Table 6. Global Medical Tranexamic Acid Sales by Type (2018-2023) & (MT)
Table 7. Global Medical Tranexamic Acid Sales Market Share by Type (2018-2023)
Table 8. Global Medical Tranexamic Acid Revenue by Type (2018-2023) & ($ million)
Table 9. Global Medical Tranexamic Acid Revenue Market Share by Type (2018-2023)
Table 10. Global Medical Tranexamic Acid Sale Price by Type (2018-2023) & (US$/Ton)
Table 11. Global Medical Tranexamic Acid Sales by Application (2018-2023) & (MT)
Table 12. Global Medical Tranexamic Acid Sales Market Share by Application (2018-2023)
Table 13. Global Medical Tranexamic Acid Revenue by Application (2018-2023)
Table 14. Global Medical Tranexamic Acid Revenue Market Share by Application (2018-2023)
Table 15. Global Medical Tranexamic Acid Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global Medical Tranexamic Acid Sales by Company (2018-2023) & (MT)
Table 17. Global Medical Tranexamic Acid Sales Market Share by Company (2018-2023)
Table 18. Global Medical Tranexamic Acid Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Medical Tranexamic Acid Revenue Market Share by Company (2018-2023)
Table 20. Global Medical Tranexamic Acid Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers Medical Tranexamic Acid Producing Area Distribution and Sales Area
Table 22. Players Medical Tranexamic Acid Products Offered
Table 23. Medical Tranexamic Acid Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Medical Tranexamic Acid Sales by Geographic Region (2018-2023) & (MT)
Table 27. Global Medical Tranexamic Acid Sales Market Share Geographic Region (2018-2023)
Table 28. Global Medical Tranexamic Acid Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Medical Tranexamic Acid Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Medical Tranexamic Acid Sales by Country/Region (2018-2023) & (MT)
Table 31. Global Medical Tranexamic Acid Sales Market Share by Country/Region (2018-2023)
Table 32. Global Medical Tranexamic Acid Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Medical Tranexamic Acid Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Medical Tranexamic Acid Sales by Country (2018-2023) & (MT)
Table 35. Americas Medical Tranexamic Acid Sales Market Share by Country (2018-2023)
Table 36. Americas Medical Tranexamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Medical Tranexamic Acid Revenue Market Share by Country (2018-2023)
Table 38. Americas Medical Tranexamic Acid Sales by Type (2018-2023) & (MT)
Table 39. Americas Medical Tranexamic Acid Sales by Application (2018-2023) & (MT)
Table 40. APAC Medical Tranexamic Acid Sales by Region (2018-2023) & (MT)
Table 41. APAC Medical Tranexamic Acid Sales Market Share by Region (2018-2023)
Table 42. APAC Medical Tranexamic Acid Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Medical Tranexamic Acid Revenue Market Share by Region (2018-2023)
Table 44. APAC Medical Tranexamic Acid Sales by Type (2018-2023) & (MT)
Table 45. APAC Medical Tranexamic Acid Sales by Application (2018-2023) & (MT)
Table 46. Europe Medical Tranexamic Acid Sales by Country (2018-2023) & (MT)
Table 47. Europe Medical Tranexamic Acid Sales Market Share by Country (2018-2023)
Table 48. Europe Medical Tranexamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Medical Tranexamic Acid Revenue Market Share by Country (2018-2023)
Table 50. Europe Medical Tranexamic Acid Sales by Type (2018-2023) & (MT)
Table 51. Europe Medical Tranexamic Acid Sales by Application (2018-2023) & (MT)
Table 52. Middle East & Africa Medical Tranexamic Acid Sales by Country (2018-2023) & (MT)
Table 53. Middle East & Africa Medical Tranexamic Acid Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Medical Tranexamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Medical Tranexamic Acid Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Medical Tranexamic Acid Sales by Type (2018-2023) & (MT)
Table 57. Middle East & Africa Medical Tranexamic Acid Sales by Application (2018-2023) & (MT)
Table 58. Key Market Drivers & Growth Opportunities of Medical Tranexamic Acid
Table 59. Key Market Challenges & Risks of Medical Tranexamic Acid
Table 60. Key Industry Trends of Medical Tranexamic Acid
Table 61. Medical Tranexamic Acid Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Medical Tranexamic Acid Distributors List
Table 64. Medical Tranexamic Acid Customer List
Table 65. Global Medical Tranexamic Acid Sales Forecast by Region (2024-2029) & (MT)
Table 66. Global Medical Tranexamic Acid Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Medical Tranexamic Acid Sales Forecast by Country (2024-2029) & (MT)
Table 68. Americas Medical Tranexamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Medical Tranexamic Acid Sales Forecast by Region (2024-2029) & (MT)
Table 70. APAC Medical Tranexamic Acid Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Medical Tranexamic Acid Sales Forecast by Country (2024-2029) & (MT)
Table 72. Europe Medical Tranexamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Medical Tranexamic Acid Sales Forecast by Country (2024-2029) & (MT)
Table 74. Middle East & Africa Medical Tranexamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Medical Tranexamic Acid Sales Forecast by Type (2024-2029) & (MT)
Table 76. Global Medical Tranexamic Acid Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Medical Tranexamic Acid Sales Forecast by Application (2024-2029) & (MT)
Table 78. Global Medical Tranexamic Acid Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Medical Tranexamic Acid Product Portfolios and Specifications
Table 81. Pfizer Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Wockhardt Ltd. Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 85. Wockhardt Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
Table 86. Wockhardt Ltd. Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Wockhardt Ltd. Main Business
Table 88. Wockhardt Ltd. Latest Developments
Table 89. FDC Limited Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 90. FDC Limited Medical Tranexamic Acid Product Portfolios and Specifications
Table 91. FDC Limited Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. FDC Limited Main Business
Table 93. FDC Limited Latest Developments
Table 94. Taicang Pharmaceutical Factory Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 95. Taicang Pharmaceutical Factory Medical Tranexamic Acid Product Portfolios and Specifications
Table 96. Taicang Pharmaceutical Factory Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. Taicang Pharmaceutical Factory Main Business
Table 98. Taicang Pharmaceutical Factory Latest Developments
Table 99. Asahi Kasei Finechem Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 100. Asahi Kasei Finechem Medical Tranexamic Acid Product Portfolios and Specifications
Table 101. Asahi Kasei Finechem Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. Asahi Kasei Finechem Main Business
Table 103. Asahi Kasei Finechem Latest Developments
Table 104. Cipla Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 105. Cipla Medical Tranexamic Acid Product Portfolios and Specifications
Table 106. Cipla Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. Cipla Main Business
Table 108. Cipla Latest Developments
Table 109. Taj Pharmaceutical Ltd. Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 110. Taj Pharmaceutical Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
Table 111. Taj Pharmaceutical Ltd. Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Taj Pharmaceutical Ltd. Main Business
Table 113. Taj Pharmaceutical Ltd. Latest Developments
Table 114. Wuhan Xinzekang Chemical Co., Ltd. Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 115. Wuhan Xinzekang Chemical Co., Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
Table 116. Wuhan Xinzekang Chemical Co., Ltd. Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Wuhan Xinzekang Chemical Co., Ltd. Main Business
Table 118. Wuhan Xinzekang Chemical Co., Ltd. Latest Developments
Table 119. Vega Pharma Limited Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 120. Vega Pharma Limited Medical Tranexamic Acid Product Portfolios and Specifications
Table 121. Vega Pharma Limited Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Vega Pharma Limited Main Business
Table 123. Vega Pharma Limited Latest Developments
Table 124. Dalian Richon Chem Co., Ltd. Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 125. Dalian Richon Chem Co., Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
Table 126. Dalian Richon Chem Co., Ltd. Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Dalian Richon Chem Co., Ltd. Main Business
Table 128. Dalian Richon Chem Co., Ltd. Latest Developments
Table 129. Nanjing Gemsen International Co., Ltd. Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 130. Nanjing Gemsen International Co., Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
Table 131. Nanjing Gemsen International Co., Ltd. Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 132. Nanjing Gemsen International Co., Ltd. Main Business
Table 133. Nanjing Gemsen International Co., Ltd. Latest Developments
Table 134. Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 135. Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
Table 136. Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 137. Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Main Business
Table 138. Changzhou Hangyu Pharmaceutical Technology Co.,Ltd. Latest Developments
Table 139. Hunan Dongting Pharmaceuticals Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 140. Hunan Dongting Pharmaceuticals Medical Tranexamic Acid Product Portfolios and Specifications
Table 141. Hunan Dongting Pharmaceuticals Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 142. Hunan Dongting Pharmaceuticals Main Business
Table 143. Hunan Dongting Pharmaceuticals Latest Developments
Table 144. Yinsheng Pharmaceutical Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 145. Yinsheng Pharmaceutical Medical Tranexamic Acid Product Portfolios and Specifications
Table 146. Yinsheng Pharmaceutical Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 147. Yinsheng Pharmaceutical Main Business
Table 148. Yinsheng Pharmaceutical Latest Developments
Table 149. Mascot Industries Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 150. Mascot Industries Medical Tranexamic Acid Product Portfolios and Specifications
Table 151. Mascot Industries Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 152. Mascot Industries Main Business
Table 153. Mascot Industries Latest Developments
Table 154. Alembic Ltd. Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 155. Alembic Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
Table 156. Alembic Ltd. Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 157. Alembic Ltd. Main Business
Table 158. Alembic Ltd. Latest Developments
Table 159. Hangzhou Lianzheng Chemicals Co., Ltd. Basic Information, Medical Tranexamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 160. Hangzhou Lianzheng Chemicals Co., Ltd. Medical Tranexamic Acid Product Portfolios and Specifications
Table 161. Hangzhou Lianzheng Chemicals Co., Ltd. Medical Tranexamic Acid Sales (MT), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 162. Hangzhou Lianzheng Chemicals Co., Ltd. Main Business
Table 163. Hangzhou Lianzheng Chemicals Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Medical Tranexamic Acid
Figure 2. Medical Tranexamic Acid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Tranexamic Acid Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Medical Tranexamic Acid Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Medical Tranexamic Acid Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Oral Liquid
Figure 12. Global Medical Tranexamic Acid Sales Market Share by Type in 2022
Figure 13. Global Medical Tranexamic Acid Revenue Market Share by Type (2018-2023)
Figure 14. Medical Tranexamic Acid Consumed in Menstrual and Postoperative Bleeding
Figure 15. Global Medical Tranexamic Acid Market: Menstrual and Postoperative Bleeding (2018-2023) & (MT)
Figure 16. Medical Tranexamic Acid Consumed in Whitening Acne
Figure 17. Global Medical Tranexamic Acid Market: Whitening Acne (2018-2023) & (MT)
Figure 18. Medical Tranexamic Acid Consumed in Hereditary Angioedema
Figure 19. Global Medical Tranexamic Acid Market: Hereditary Angioedema (2018-2023) & (MT)
Figure 20. Medical Tranexamic Acid Consumed in Others
Figure 21. Global Medical Tranexamic Acid Market: Others (2018-2023) & (MT)
Figure 22. Global Medical Tranexamic Acid Sales Market Share by Application (2022)
Figure 23. Global Medical Tranexamic Acid Revenue Market Share by Application in 2022
Figure 24. Medical Tranexamic Acid Sales Market by Company in 2022 (MT)
Figure 25. Global Medical Tranexamic Acid Sales Market Share by Company in 2022
Figure 26. Medical Tranexamic Acid Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Medical Tranexamic Acid Revenue Market Share by Company in 2022
Figure 28. Global Medical Tranexamic Acid Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Medical Tranexamic Acid Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Medical Tranexamic Acid Sales 2018-2023 (MT)
Figure 31. Americas Medical Tranexamic Acid Revenue 2018-2023 ($ Millions)
Figure 32. APAC Medical Tranexamic Acid Sales 2018-2023 (MT)
Figure 33. APAC Medical Tranexamic Acid Revenue 2018-2023 ($ Millions)
Figure 34. Europe Medical Tranexamic Acid Sales 2018-2023 (MT)
Figure 35. Europe Medical Tranexamic Acid Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Medical Tranexamic Acid Sales 2018-2023 (MT)
Figure 37. Middle East & Africa Medical Tranexamic Acid Revenue 2018-2023 ($ Millions)
Figure 38. Americas Medical Tranexamic Acid Sales Market Share by Country in 2022
Figure 39. Americas Medical Tranexamic Acid Revenue Market Share by Country in 2022
Figure 40. Americas Medical Tranexamic Acid Sales Market Share by Type (2018-2023)
Figure 41. Americas Medical Tranexamic Acid Sales Market Share by Application (2018-2023)
Figure 42. United States Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Medical Tranexamic Acid Sales Market Share by Region in 2022
Figure 47. APAC Medical Tranexamic Acid Revenue Market Share by Regions in 2022
Figure 48. APAC Medical Tranexamic Acid Sales Market Share by Type (2018-2023)
Figure 49. APAC Medical Tranexamic Acid Sales Market Share by Application (2018-2023)
Figure 50. China Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Medical Tranexamic Acid Sales Market Share by Country in 2022
Figure 58. Europe Medical Tranexamic Acid Revenue Market Share by Country in 2022
Figure 59. Europe Medical Tranexamic Acid Sales Market Share by Type (2018-2023)
Figure 60. Europe Medical Tranexamic Acid Sales Market Share by Application (2018-2023)
Figure 61. Germany Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Medical Tranexamic Acid Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Medical Tranexamic Acid Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Medical Tranexamic Acid Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Medical Tranexamic Acid Sales Market Share by Application (2018-2023)
Figure 70. Egypt Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Medical Tranexamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Medical Tranexamic Acid in 2022
Figure 76. Manufacturing Process Analysis of Medical Tranexamic Acid
Figure 77. Industry Chain Structure of Medical Tranexamic Acid
Figure 78. Channels of Distribution
Figure 79. Global Medical Tranexamic Acid Sales Market Forecast by Region (2024-2029)
Figure 80. Global Medical Tranexamic Acid Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Medical Tranexamic Acid Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Medical Tranexamic Acid Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Medical Tranexamic Acid Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Medical Tranexamic Acid Revenue Market Share Forecast by Application (2024-2029)


More Publications